Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A.

作者: Wei Wang , Robert J.B. MaCaulay

DOI: 10.1002/(SICI)1097-0215(19990730)82:3<430::AID-IJC17>3.0.CO;2-9

关键词:

摘要: Medulloblastoma is a malignant cerebellar tumor usually manifesting in childhood. We have previously shown that blocking the mevalonate pathway with lovastatin, competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, inhibits medulloblastoma proliferation and induces apoptosis vitro. The underlying mechanism may involve post-translational modification important mitogenic signal-transduction proteins. show p21 ras processing blocked by suggesting inhibition isoprenylation be lovastatin-induced apoptosis. To test this hypothesis, manumycin A, an antibiotic which farnesyl protein transferase thus farnesylation, was administered to 4 cell lines found farnesylation followed time- dose-dependent manner. However, death induced uniformly more rapid efficient, requiring only 12 24 hr treatment, than apoptosis, required 36 96 (depending on line tested). In addition, unlike caused cell-cycle arrest G1 phase HMG-CoA reductase gene up-regulation, had no effect cycle resulted down-regulation expression. both lovastatin- A-treated cells, cellular cysteine protease precursor (CPP32) activated, confirming occurrence

参考文章(32)
J R Silber, M S Berger, G E Keles, M S Bobola, J Srinivasan, D D Kolstoe, Establishment and characterization of four human medulloblastoma-derived cell lines. Oncology Research. ,vol. 7, pp. 493- 503 ,(1995)
L. Gutierrez, A. I. Magee, C. J. Marshall, J. F. Hancock, Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. The EMBO Journal. ,vol. 8, pp. 1093- 1098 ,(1989) , 10.1002/J.1460-2075.1989.TB03478.X
Andrew D. Hamilton, Jiazhi Sun, Karine Miquel, Yimin Qian, Anne Pradines, Gilles Favre, Saïd M. Sebti, GGTI-298 Induces G0-G1 Block and Apoptosis Whereas FTI-277 Causes G2-M Enrichment in A549 Cells Cancer Research. ,vol. 57, pp. 1846- 1850 ,(1997)
A. I. Magee, L. Gutierrez, I. A. McKay, C. J. Marshall, A. Hall, Dynamic fatty acylation of p21N-ras. The EMBO Journal. ,vol. 6, pp. 3353- 3357 ,(1987) , 10.1002/J.1460-2075.1987.TB02656.X
Elaine Rands, Allen Oliff, Nancy E. Kohl, Neal Rosen, Jackson B. Gibbs, Laura Sepp-Lorenzino, Zhenping Ma, A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines Cancer Research. ,vol. 55, pp. 5302- 5309 ,(1995)
Robert J.B. Macaulay, Wei Wang, Jim Dimitroulakos, Lawrence E. Becker, Herman Yeger, Lovastatin-induced Apoptosis of Human Medulloblastoma Cell Lines in vitro Journal of Neuro-oncology. ,vol. 42, pp. 1- 11 ,(1999) , 10.1023/A:1006164406202
Hiroshi Mitsuzawa, Fuyuhiko Tamanoi, [5] In vivo assays for farnesyltransferase inhibitors with Saccharomyces cereuisiae Methods in Enzymology. ,vol. 250, pp. 43- 51 ,(1995) , 10.1016/0076-6879(95)50061-8
P F Lebowitz, J P Davide, G C Prendergast, Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Molecular and Cellular Biology. ,vol. 15, pp. 6613- 6622 ,(1995) , 10.1128/MCB.15.12.6613
Shoichiro Sumi, R.Daniel Beauchamp, Courtney M. Townsend, Tatsuo Uchida, Manabu Murakami, Srinivasan Rajaraman, Jin Ishizuka, James C. Thompson, Inhibition of pancreatic adenocarcinoma cell growth by lovastatin Gastroenterology. ,vol. 103, pp. 982- 989 ,(1992) , 10.1016/0016-5085(92)90032-T
Timothy S. Vincent, Ernst Wulfert, Ezio Merler, Inhibition of growth factor signaling pathways by lovastatin. Biochemical and Biophysical Research Communications. ,vol. 180, pp. 1284- 1289 ,(1991) , 10.1016/S0006-291X(05)81334-8